Your browser doesn't support javascript.
Effectiveness of a telerehabilitation intervention using ReCOVery APP of long COVID patients: a randomized, 3-month follow-up clinical trial.
Samper-Pardo, M; León-Herrera, S; Oliván-Blázquez, B; Méndez-López, F; Domínguez-García, M; Sánchez-Recio, R.
  • Samper-Pardo M; Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
  • León-Herrera S; Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain.
  • Oliván-Blázquez B; Institute for Health Research Aragon (IISAragon), Zaragoza, Spain. barbaraolivan@gmail.com.
  • Méndez-López F; Department of Psychology and Sociology, University of Zaragoza, Zaragoza, Spain. barbaraolivan@gmail.com.
  • Domínguez-García M; Network for Research on Chronicity, Primary Care, and Health Promotion (RICAPPS), Barcelona, Spain. barbaraolivan@gmail.com.
  • Sánchez-Recio R; Institute for Health Research Aragon (IISAragon), Zaragoza, Spain.
Sci Rep ; 13(1): 7943, 2023 05 16.
Article in English | MEDLINE | ID: covidwho-2326033
ABSTRACT
The main objective of this study is to analyze the clinical efficacy of telerehabilitation in the recovery of Long COVID patients through ReCOVery APP for 3 months, administered in the Primary Health Care context. The second objective is to identify significant models associated with an improvement in the study variables. An open-label randomized clinical trial was conducted using two parallel groups of a total of 100 Long COVID patients. The first group follows the treatment as usual methods established by their general practitioner (control group) and the second follows the same methods and also uses ReCOVery APP (intervention group). After the intervention, no significant differences were found in favour of the group intervention. Regarding adherence, 25% of the participants made significant use of the APP. Linear regression model establishes that the time of use of ReCOVery APP predicts an improvement in physical function (b = 0.001; p = 0.005) and community social support (b = 0.004; p = 0.021). In addition, an increase in self-efficacy and health literacy also contribute to improving cognitive function (b = 0.346; p = 0.001) and reducing the number of symptoms (b = 0.226; p = 0.002), respectively. In conclusion, the significant use of ReCOVery APP can contribute to the recovery of Long COVID patients. Trial Registration No. ISRCTN91104012.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Mobile Applications / Telerehabilitation / COVID-19 Type of study: Cohort study / Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Sci Rep Year: 2023 Document Type: Article Affiliation country: S41598-023-35058-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Mobile Applications / Telerehabilitation / COVID-19 Type of study: Cohort study / Experimental Studies / Prognostic study / Randomized controlled trials Topics: Long Covid Limits: Humans Language: English Journal: Sci Rep Year: 2023 Document Type: Article Affiliation country: S41598-023-35058-y